Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| secondary structure | involved_in | process | 0.95 |
| protein folding | involved_in | process | 0.95 |
| amino acid sequence | involved_in | process | 0.90 |
| Distant Pqtl Effects | mediates | mechanism | 0.88 |
| Alzheimer'S Disease | biomarker_for | disease | 0.88 |
| NEURODEGENERATION | associated_with | disease | 0.80 |
| protein_quantitative_trait_loci | mediates | phenotype | 0.80 |
| PROTEOSTATIC INTEGRITY | regulates | biological_process | 0.80 |
| ORGANELLE COMMUNICATION | regulates | biological_process | 0.80 |
| NETWORK-LEVEL COMPUTATION | regulates | biological_process | 0.80 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Positive Indiv | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| AD Combination Therapy Trial: Anti-Aβ + Anti-Tau | clinical | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $180,000 |
| Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investig | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| ApoE4 Function in Alzheimer's Disease | validation | Alzheimer's Disease | 0.400 | 0.50 | mouse | proposed | $360,000 |
| Blood-Based Biomarker Panel for Early AD Detection | clinical | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $220,000 |
| Down Syndrome Alzheimer's Disease: Mechanisms and Therapeutic Timing | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| Metal Ion Homeostasis Dysregulation in Alzheimer's Disease | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
| Sex Differences in Alzheimer's Disease — mechanisms and therapeutic im | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| s:** - Dose-response studies showing therapeutic window without toxici | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Multiscale Computational Modeling of Protein Aggregation Kinetics | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Prion Strain Diversity and Selective Vulnerability in CJD | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Proteasome-Ubiquitin System Dysfunction Validation in Parkinson's Dise | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Protein Aggregation Kinetic Validation Results | validation | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $120,000 |
| Experiment Validation: In vitro ThT Assay | validation | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $160,000 |
| Viral Infections and Alzheimer's Disease — causal mechanisms and thera | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Proposed experiment from debate on Microglia activate astrocytes via I | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| s:** - Temporal analysis showing mitochondrial defects precede other p | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| ALS Progression Rate Heterogeneity — mechanism and biomarker predictor | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress [PMID:40066224] | Liu H, Zhou Y, Wang Z, Liu D, Li Y, Lai | MedComm (2020) | 2025 | 1 |
| From sleep to cancer to neurodegenerative disease: the crucial role of Hsp70 in [PMID:37643058] | Ghosh S, Vashisth K, Ghosh S, Han SS, Bh | J Biomol Struct Dyn | 2024 | 1 |
| Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteom [PMID:37652020] | Yuan S, Xu F, Li X, Chen J, Zheng J, Man | Cell Rep Med | 2023 | 1 |
| Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044] | Calvier L, Herz J, Hansmann G | JACC Basic Transl Sci | 2022 | 1 |
| ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. [PMID:36348357] | Raulin AC, Doss SV, Trottier ZA, Ikezu T | Mol Neurodegener | 2022 | 1 |
| DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-asso [PMID:34614409] | Li Y, Xu J, Lu Y, Bian H, Yang L, Wu H, | Cell Metab | 2021 | 1 |
| Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216] | Banik SM, Pedram K, Wisnovsky S, Ahn G, | Nature | 2020 | 1 |
| Initiation of Parental Genome Reprogramming in Fertilized Oocyte by Splicing Kin [PMID:32169215] | Gou LT, Lim DH, Ma W, Aubol BE, Hao Y, W | Cell | 2020 | 1 |
| Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventin [PMID:30595089] | Brophy ML, Dong Y, Tao H, Yancey PG, Son | Circ Res | 2019 | 1 |
| KIF5A de novo mutation associated with myoclonic seizures and neonatal onset pro [PMID:27414745] | Rydzanicz M, Jagła M, Kosinska J, Tomasi | Clin Genet | 2017 | 1 |
| Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical [PMID:28381441] | Shinohara M, Tachibana M, Kanekiyo T, Bu | J Lipid Res | 2017 | 1 |
| ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fert [PMID:23177736] | Zheng G, Dahl JA, Niu Y, Fedorcsak P, Hu | Mol Cell | 2013 | 1 |
| TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and [PMID:23395375] | van Spronsen M, Mikhaylova M, Lipka J, S | Neuron | 2013 | 1 |
| Delineation of the TRAK binding regions of the kinesin-1 motor proteins. [PMID:24161670] | Randall TS, Moores C, Stephenson FA | FEBS Lett | 2013 | 1 |
| Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancie [PMID:19821156] | Molvarec A, Tamási L, Losonczy G, Madách | Cell Stress Chaperones | 2010 | 1 |
| Integrating NHANES and network toxicology to assess the impact of organophosphat [PMID:41804832] | Dai K, Huang Y, Cai H, Zhong G, Xie Z, W | Toxicology mechanisms and meth | 2026 | 0 |
| Crystal structures reveal phosphorylation-dependent disruption of the heat shock [PMID:41833837] | Stewart M, Paththamperuma C, McCann C, C | Cell stress & chaperones | 2026 | 0 |
| Aryl hydrocarbon receptor-mediated transcriptional regulation of HSP70 exacerbat [PMID:41725010] | Wen M, Li J, Li Y, Hun M, Yang T, Meng Y | Cell & bioscience | 2026 | 0 |
| Palmitoylation-Mediated Ubiquitination of SRPK1 Regulates Ferroptosis in High-Fa [PMID:41610308] | Tan XH, Li KF, Yuan YM, Xia MC, Zhao FZ | Adv Sci (Weinh) | 2026 | 0 |
| Single-cell transcriptomics reveal heat shock protein dysregulation in severe SA [PMID:41772029] | Suzuki T, Sato Y, Suzuki M, Fukuda Y, Iw | Scientific reports | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PROTEIN in their description or question text
Score: 0.624 · neurodegeneration · 2026-04-02
## Mechanistic Overview Serine/Arginine-Rich Protein Kinase Modulation starts from the claim that modulating SRPK1 withi
Score: 0.621 · neurodegeneration · 2026-04-02
## Mechanistic Overview Designer TRAK1-KIF5 fusion proteins accelerate therapeutic mitochondrial delivery starts from th
Score: 0.620 · protein biochemistry · 2026-04-21
**Molecular Mechanism and Rationale** The J-protein co-chaperone system represents a sophisticated cellular quality con
Score: 0.620 · neurodegeneration · 2026-04-22
## Mechanistic Overview Tau fibrils expose neuronal phosphatidylserine and heat-shock protein 70, driving microglial non
Score: 0.606 · neurodegeneration · 2026-04-25
Specific lipoprotein particles bind fibril surfaces and preserve polymorph architecture and seeding fidelity outside the
Score: 0.540 · neuroscience · 2026-04-26
MTS-dGFP fusion construct requires intact TOM40/TOM20 translocase for mitochondrial import, serving as direct read-out o
Score: 0.507 · neuroinflammation · 2026-04-21
## Mechanistic Overview Circulating IBA1 Protein Absorption/Interference with Detection starts from the claim that modul
Score: 0.506 · proteomics · 2026-04-25
VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking
Score: 0.489 · neurodegeneration · 2026-04-25
Electrostatic bridging by glycans and low-abundance proteins preserves disease-relevant fibril architecture.
Score: 0.480 · molecular neurobiology · 2026-04-25
An auxiliary protein, such as TDP-43, FUS, or an hnRNP family member, may bind lncRNA-0021 and/or mmu-miR-6361 to increa
Score: 0.472 · proteomics · 2026-04-25
CHIP E3 Ligase Enhancement to Target Synaptic Proteins for Degradation
Score: 0.469 · proteomics · 2026-04-25
Hsp70 cochaperone BAG3-mediated Autophagy Activation for Synaptic Protein Quality Control
Score: 0.450 · neurodegeneration · 2026-04-25
HDAC6 Inhibitor Therapy for Pan-Neurodegenerative Protein Homeostasis
Score: 0.380 · metabolomics · 2026-04-25
Apolipoprotein E4-Mediated Metabolic Dysfunction Correction via Liver X Receptor Agonism
Score: 0.360 · neurodegeneration · 2026-04-21
## Mechanistic Overview Direct APOE4-TDP-43 Protein-Protein Interaction Promoting Aggregation Seeding starts from the cl